DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Bruix J, Qin S, Merle P. et al.
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet 2017;
389: 56-66

Download Bibliographical Data

Access:
Access:
Access: